Theravance Biopharma Inc. (TBPH)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▼ | |
| Q3 2021 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 37.84% | 3,750,000 | 0.26 | |
| Q2 2021 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 13.45% | 1,175,000 | 0.14 | |
| Q3 2017 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 0.38% | 35,177 | 0.02 | |
| Q4 2016 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 26.16% | 1,923,000 | 0.81 | |
| Q2 2016 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 13.07% | 850,000 | 0.26 | |
| Q1 2016 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 1.26% | 80,963 | 0.02 | |
| Q2 2015 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 0.84% | 53,451 | 0.01 | |
| Q1 2015 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 5.04% | 305,349 | 0.09 | |
| Q2 2014 | |||||
| ≡ | Seth Klarman - Baupost Group | Buy | 6,061,228 | 3.20 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.